Results 211 to 220 of about 4,611 (302)
Classical decay rates for molecules in the presence of a spherical surface: A complete treatment
Young Sik Kim +2 more
openalex +1 more source
The biomimetic nanoplatform IMNP (ETS1 pDNA/PBAE@ITP‐MM) undergoes targeted disassembly at inflammatory vascular sites to release the ETS1 plasmid (pETS1). This release initiates a cascade of effects that inhibit pathogenic pathways and support immune homeostasis. (Abbreviations: EndMT, endothelial‐to‐mesenchymal transition; EC, endothelial cell; TC, T
Feng Zhang +13 more
wiley +1 more source
The use of effective core potentials in Hirshfeld atom refinement: making quantum crystallography faster in <i>NoSpherA2</i>. [PDF]
Kleemiss F +3 more
europepmc +1 more source
Over half of cancer patients undergo radiotherapy. Laser ablation enabled the synthesis of immiscible Au‐Fe‐B nanoparticles designed as degradable bimodal radiosensitizers for X‐ray radiotherapy (XRT), boron neutron capture therapy (BNCT), and bimodal imaging for X‐ray computed tomography (CT) and magnetic resonance imaging (MRI). These nanosensitizers
Michael Bissoli +15 more
wiley +1 more source
Research on robot positioning error compensation algorithm based on the Dog Leg and PSONN algorithm. [PDF]
Li M, Lu R.
europepmc +1 more source
Retrieving complete spherical Bouguer and isostatic gravity anomalies using global gravity forward models [PDF]
Metehan Uz, E. Sinem Ince
openalex +1 more source
A two‐phase workflow (OFAT screening followed by central composite design) maps how processing variables tune PFCE‐PLGA nanoparticle size, dispersity, surface charge, loading, and 19F‐MRI signal. In situ, time‐resolved synchrotron SAXS tracks albumin‐corona growth on intact dispersions and reveals PFCE‐dependent adsorption pathways.
Joice Maria Joseph +11 more
wiley +1 more source
Search for active and inactive ion insertion sites in organic crystalline materials. [PDF]
Gopidi HR +11 more
europepmc +1 more source
The synthesis process of MM@PCD@QNPs and its potential mechanism for treating PCOS. (A) Assembly steps of MM@PCD@QNPs. (B) Synthesis and decomposition of MM@PCD@QNPs. (C) Potential therapeutic mechanisms of MM@PCD@QNPs for PCOS. PCD, PABP conjugated with DEX polymer; QUR, quercetin; CDI, N, N′‐carbonyldiimidazole; DEX, dextran; PABP, 4‐(hydroxymethyl ...
Wenzhu Li +9 more
wiley +1 more source

